The Genentech® Access to Care Foundation (GATCF) was created to help patients who are uninsured—or who have been denied coverage for LUCENTIS® (ranibizumab injection) by their health plans. GATCF might be able to help those patients receive LUCENTIS treatment if they meet specific financial and medical criteria.
To apply to GATCF, you must complete and submit the Statement of Medical Necessity (SMN) form and have your patient complete and submit a Patient Authorization and Notice of Release of Information (PAN) form.
When completing the SMN, be sure to complete all sections of the form.
Once we receive your patient’s information, LUCENTIS Access Solutions will contact the patient within 24 hours with further instructions. This may include verifying financial eligibility.
Additional GATCF Program details:
GATCF has the right to modify or end this program at any time and to verify the accuracy of the information you submit.